FDA Drug Application (201661) for NIKKI by LUPIN LTD

Back to FDA Applications sponsored by LUPIN LTD

Application Number201661
Product Number001
FormTABLET;ORAL
Dosage3MG;0.02MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNIKKI
Active IngredientDROSPIRENONE; ETHINYL ESTRADIOL

Active IngredientCount
List of drugs with Active Ingredient DROSPIRENONE12
List of drugs with Active Ingredient ETHINYL ESTRADIOL226


Back to FDA Applications sponsored by LUPIN LTD